Foreign Investors Up Stakes In Nine of 11 Bioventures in Japan (Japan)
This article was originally published in PharmAsia News
Executive Summary
An increase in international investment has provided a much-needed boost to 9 of 11 Japanese biotechnology ventures. Even though many of these companies are losing money, foreign investment continues thanks to the promising new drugs they have in development. "Foreign institutional investors are favoring firms with a hand in developing promising drugs, even though they are bleeding red ink," says Kiyokazu Yamazaki at Ichiyoshi Research Institute Inc. (Click here for more